Anthracycline News and Research

RSS
Anthracycline is a type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.
Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Advances in treatment have improved the chances of survival for young patients with cancer

Advances in treatment have improved the chances of survival for young patients with cancer

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen announces acquisition of Cardioxane from Novartis

African-American women with breast cancer more likely to develop heart failure

African-American women with breast cancer more likely to develop heart failure

Chroma Therapeutics, CTI announce results from tosedostat Phase 2 study on AML

Chroma Therapeutics, CTI announce results from tosedostat Phase 2 study on AML

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Results from eribulin and capecitabine phase III comparison trial on metastatic breast cancer

Results from eribulin and capecitabine phase III comparison trial on metastatic breast cancer

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Results of Halaven Phase III study in metastatic breast cancer presented at 2012 CTRC-AACR SABCS

Results of Halaven Phase III study in metastatic breast cancer presented at 2012 CTRC-AACR SABCS

No advantage of continuous over bolus doxorubicin in ALL children

No advantage of continuous over bolus doxorubicin in ALL children

Trastuzumab increases risk of heart failure in older women with breast cancer

Trastuzumab increases risk of heart failure in older women with breast cancer

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Most basal-like breast and ovarian tumors have similar genetic origins

Most basal-like breast and ovarian tumors have similar genetic origins